doi: 10.1200/JCO.2005.04.9296.
Rethinking risk-benefit assessment for phase I cancer trials
Affiliations
- PMID: 16809725
- DOI: 10.1200/JCO.2005.04.9296
Item in Clipboard
Rethinking risk-benefit assessment for phase I cancer trials
J Clin Oncol.
.
No abstract available
Comment in
-
Phase I trials may not need to be viewed as extraordinarily different from other clinical research.J Clin Oncol. 2006 Oct 1;24(28):e47. doi: 10.1200/JCO.2006.08.1182. J Clin Oncol. 2006. PMID: 17008685 No abstract available.
-
Dynamic and modern: bringing the ethics of phase I trials up to date.J Clin Oncol. 2006 Nov 10;24(32):5178-9; author reply 5179-80. doi: 10.1200/JCO.2006.09.1207. J Clin Oncol. 2006. PMID: 17093287 No abstract available.
Similar articles
-
Dynamic and modern: bringing the ethics of phase I trials up to date.J Clin Oncol. 2006 Nov 10;24(32):5178-9; author reply 5179-80. doi: 10.1200/JCO.2006.09.1207. J Clin Oncol. 2006. PMID: 17093287 No abstract available.
-
Phase I trials may not need to be viewed as extraordinarily different from other clinical research.J Clin Oncol. 2006 Oct 1;24(28):e47. doi: 10.1200/JCO.2006.08.1182. J Clin Oncol. 2006. PMID: 17008685 No abstract available.
-
Phase I research and the meaning of direct benefit.J Pediatr. 2006 Jul;149(1 Suppl):S20-4. doi: 10.1016/j.jpeds.2006.04.046. J Pediatr. 2006. PMID: 16829237
-
Controversies in multi-institutional phase I clinical trials.Clin Adv Hematol Oncol. 2009 Aug;7(8):518-20. Clin Adv Hematol Oncol. 2009. PMID: 19927978 Review. No abstract available.
-
Research involving adolescents as subjects : ethical considerations.Ann N Y Acad Sci. 2008;1135:280-6. doi: 10.1196/annals.1429.039. Ann N Y Acad Sci. 2008. PMID: 18574234 Review.
Cited by
-
Communication and informed consent in phase 1 trials: a review of the literature from January 2005 to July 2009.Support Care Cancer. 2010 Sep;18(9):1115-21. doi: 10.1007/s00520-010-0836-7. Epub 2010 Mar 4. Support Care Cancer. 2010. PMID: 20204418 Review.
-
Phase I oncology trials incorporating patient choice of dose.Br J Cancer. 2012 Sep 25;107(7):1022-4. doi: 10.1038/bjc.2012.378. Epub 2012 Aug 28. Br J Cancer. 2012. PMID: 22929891 Free PMC article.
-
Ethical and practical considerations for cell and gene therapy toward an HIV cure: findings from a qualitative in-depth interview study in the United States.BMC Med Ethics. 2022 Apr 9;23(1):39. doi: 10.1186/s12910-022-00780-1. BMC Med Ethics. 2022. PMID: 35397551 Free PMC article.
-
A population pharmacokinetic model of AT9283 in adults and children to predict the maximum tolerated dose in children with leukaemia.Br J Clin Pharmacol. 2017 Aug;83(8):1713-1722. doi: 10.1111/bcp.13260. Epub 2017 Mar 5. Br J Clin Pharmacol. 2017. PMID: 28177130 Free PMC article.
-
Developing a Model of the Benefits and Burdens of Research Participation in Cancer Clinical Trials.AJOB Prim Res. 2012;3(2):10-23. doi: 10.1080/21507716.2011.653472. AJOB Prim Res. 2012. PMID: 24748992 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
